What question did this study set out to answer?

To examine the unique aspects of hypercalcemia of malignancy in children, including its causes and implications.

April 13, 2026Pediatric Blood & Cancer0 citations

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

Key Points

To examine the unique aspects of hypercalcemia of malignancy in children, including its causes and implications.
Narrative review of existing literature on hypercalcemia in pediatric malignancies.
Evaluation of clinical presentations and management strategies for hypercalcemia of malignancy.
Analysis of the relationship between calcium levels and prognosis in childhood malignancies.
Hypercalcemia of malignancy in children often correlates with acute lymphoblastic leukemia.
Symptomatic hypercalcemia suggests a poor prognosis in pediatric malignancy cases.
Pediatric HCM is less common than in adults, occurring in less than 1% of cases.

Abstract

ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon. Unlike HCM in adults, in which solid tumors are the primary cause, pediatric HCM is most frequently associated with hematological malignancies such as acute lymphoblastic leukemia (ALL). Knowledge regarding the duration of malignancy‐related hypercalcemia is obtained by evaluating the increasing trend in calcium levels at clinical visits, which provides information about the stage and prognosis of the malignancy. Suddenly developing, symptomatic and severe hypercalcemia indicates a poor prognosis in patients with malignancy. In this narrative review, we discuss the distinct pathophysiological mechanisms and clinical presentation of HCM in children and the current therapeutic strategies.

Ask AI

Helpful

Bookmark

View Full Paper